Overexpressed or activated hepatocyte growth factor receptor, encoded by the MET proto-oncogene, was found in the majority of colorectal carcinomas (CRCs), whose stepwise progression to malignancy requires transcriptional activation of b-catenin. We here demonstrate that a functional crosstalk between Met and b-catenin signaling sustains and increases CRC cell invasive properties. Hepatocyte growth factor (HGF) stimulation prompts b-catenin tyrosine phosphorylation and dissociation from Met, and upregulates b-catenin expression via the phosphatidylinositol 3-kinase pathway in conditions that mimic those found by the invading and metastasizing cells. Additionally, a transcriptionally active form of b-catenin, known to be oncogenic, enhances Met expression. Furthermore, HGF treatment increases the activity of the b-catenin-regulated T-cell factor transcription factor in cells expressing the wild-type or the oncogenic b-catenin. In the mirror experiments, either Met or b-catenin knocking down also reduces their protein level. In biological assays, b-catenin knocking down abrogates the HGF-induced motile phenotype, whereas active b-catenin fosters ligand-independent cell scattering. Met and b-catenin also cooperate in promoting entry into the cell cycle and in protecting cells from apoptosis. In conclusion, Met and b-catenin pathways are mutually activated in CRC cells. This might generate a selfamplifying positive feedback loop resulting in the upregulation of the invasive growth properties of CRC cells.
Introduction
The hepatocyte growth factor receptor (HGFR), encoded by the MET proto-oncogene, provides all the mandatory signals for invasive growth, a complex morphogenetic program by which epithelial cells are instructed to disrupt intercellular junctions, to acquire a motile phenotype, to evade the primary site of accretion and finally to colonize new districts (Trusolino and Comoglio, 2002) . Deregulation of HGFR activity is profoundly involved in the aberrant turning on of the invasive growth program and strictly correlates with a higher metastatic potential of cancer cells and with poor prognosis in a plethora of aggressive tumors (reviewed by Trusolino and Comoglio, 2002; Birchmeier et al., 2003; Corso et al., 2005) .
A remarkable similarity exists between colorectal carcinoma (CRC) progression and the operational strategies managed by HGF/HGFR during invasive growth: colorectal cells undergo stepwise genetic alterations that gradually foster clonal expansion, protrusion into the surrounding tissues, apoptosis resistance and eventually metastatic dissemination (Sancho et al., 2004; Radtke and Clevers, 2005) . Hence, a pivotal role of HGFR in the orchestration of colorectal cancer progression toward metastasis can be argued. Accordingly, HGFR is overexpressed in a high proportion of colon adenomas and carcinomas (Di Renzo et al., 1995; Fazekas et al., 2000) , and HGFR expression directly relates to CRC malignancy (Takeuchi et al., 2003) and tumorigenicity in animal models (Herynk et al., 2003) . Moreover, HGF is found within the tumor microenvironment, suggesting a role for paracrine HGF/ HGFR interactions in promoting colorectal progression (Wielenga et al., 2000) .
Despite these observations, how HGFR activation is involved in CRC development remains poorly understood. Instrumental in CRC development is Wnt/bcatenin signaling. Following Wnt stimulation, b-catenin translocates into the nucleus and activates the T-cell factor (TCF) family of transcription factors; in the absence of Wnt signaling, b-catenin is instead tagged for proteasome-dependent degradation (Henderson and Fagotto, 2002; Lustig and Behrens, 2003; Logan and Nusse, 2004) . Deregulation of this pathway leads to aberrant TCF-mediated transcription and ultimately to unrestricted cell proliferation (Giles et al., 2003; Gregorieff and Clevers, 2005; Reya and Clevers, 2005) . It was found that transcription of the MET gene is increased by Wnt stimulation in early dysplastic lesions (Boon et al., 2002) , even if HGFR can lead to enhanced CRC transformation irrespective of Wnt (Boon et al., 2005) . In addition, HGFR promotes the transcriptional potential of b-catenin in non-colorectal tumor cells (Danilkovitch-Miagkova et al., 2001 ).
We here demonstrate the existence of a functional loop between HGFR and b-catenin in CRC cells that leads to the amplification of biological processes required for colorectal cancer progression such as cell proliferation, survival, scatter and motility.
Results

HGF modulates b-catenin level and activity
We treated CRC cells with apoptogenic stimuli endowed with oncogenic relevance. In fact, in an early phase of the adenoma-carcinoma sequence, CRC cells must face nutrient deprivation inside the growing tumor mass.
Later on, tumor cells detach from the primary site of accretion and must overwhelm anoikis, a form of apoptosis induced by inadequate cell-matrix interactions (Grossmann, 2002) . We selected the HCT116 and COLO741 cell lines (Rowan et al., 2000) . Both expressed the MET proto-oncogene-encoded HGFR, and this was activated, that is, tyrosine phosphorylated, in response to HGF treatment (Figure 1a) . Experiments produced consistent results in both cell lines; thus, for the sake of brevity, data obtained with a single cell line are shown for each experiment.
We exposed CRC cells to in vitro conditions that mimic nutrient deprivation or anoikis, that is, serum depletion or substrate detachment. We observed that, either in starved or detached cells, but not in control conditions, HGF increased expression of both b-catenin protein ( Figure 1b ) and mRNA ( Figure 1c and data not shown). In addition, cell treatment with LY294002, a selective phosphatidylinositol 3-kinase (PI3K) inhibitor, strongly decreased b-catenin upregulation, showing that HGF increased b-catenin protein level in a PI3K-dependent manner (Figure 1b) . Conversely, either rapamycin, a highly specific mammalian target of rapamycin (mTOR) blocker, or PD98059, which targets the upstream extracellular signal-regulated kinase activator mitogen-induced extracellular kinase 1 (MEK1), did not modulate b-catenin (Figure 1b) . In a mirror experiment, we knocked down HGFR expression by transducing cells with specific small interfering RNAs (siRNAs). As depicted in Figure 1d , HGFR knocking down markedly reduced b-catenin protein level.
We then investigated whether HGFR could interact physically with b-catenin in a complex, as it was reported in other cell models (Monga et al., 2002; Herynk et al., 2003) . We found that HGFR and bcatenin co-immunoprecipitated in CRC cells (Figure 2a and b). HGF stimulation prompted dissociation of the b-catenin/HGFR complex, enhanced b-catenin tyrosine phosphorylation, inhibited glycogen synthase kinase-3b (GSK3b) activity through phosphorylation of GSK3b Ser9 residue and decreased b-catenin serine/threonine phosphorylation (Figure 2a-d) . It is noteworthy that both tyrosine phosphorylation and inhibition of GSK3b-dependent serine/threonine phosphorylation are involved in b-catenin nuclear translocation and transcriptional activation, whereas b-catenin serine/ threonine phosphorylation is required for its degradation Harris and Peifer, 2005) .
As HGF promoted a change in b-catenin phosphorylation pattern and its dissociation from the transmembrane HGFR, we argued that this could lead to b-catenin nuclear relocalization and to the consequent activation of the TCF family of transcription factors. In accord with our hypothesis, HGF induced translocation of the cytosolic b-catenin into the nucleus (Figure 2e) . HGF also increased the activity of a luciferase reporter gene placed downstream to TCF-specific sequences, either in HGFR-transfected COS cells or in CRC cells, both expressing endogenous b-catenin (Figure 2f ). The HGF-mediated increase in luciferase activity was paralleled in CRC cells by the induction of the bcatenin/TCF target genes cyc D1 and c-myc (Figure 2g) .
In all, these data indicate that the HGF/HGFR transduction axis regulates b-catenin expression level and transcription of b-catenin/TCF target genes in CRC cells.
A functional loop between HGFR and b-catenin enhances TCF-mediated transcription In turn, we found that b-catenin regulates HGFR protein expression in the same CRC cells. In fact, knocking down b-catenin with specific siRNAs downregulated the HGFR expression level (Figure 3a) . Conversely, HGFR expression was increased both at the protein and at the mRNA level after CRC cell transfection with an oncogenic, constitutive active form of b-catenin (DN-bcat; see Materials and methods; Figure 3b and c). Moreover, we induced expression of wild-type human b-catenin in HGFR-transfected COS cells, or expression of DN-bcat in CRC cells, in order to prompt a high TCF-dependent luciferase response. Notwithstanding the high transcriptional response recorded following b-catenin hyperactivation in these independent cell models, HGF treatment further and strongly increased luciferase activity in both experimental settings (Figure 3d and e).
Together, our data demonstrate the existence of a functional crosstalk linking HGFR and b-catenin signaling and resulting in transcriptional activation downstream to b-catenin.
HGF and b-catenin cooperate to promote the invasive growth program in CRC cells
Once established that HGF regulates b-catenin transcriptional activity, we investigated whether b-catenin could in turn play a role in the biological programs required for the invasive growth process promoted by HGF.
First, we investigated the involvement of b-catenin in CRC cell scattering and motility. As expected, we found that HGF caused scattering, that is, loosening of cellto-cell contacts and of island-shaped cell aggregates, of CRC cells (Figure 4a ). Notably, this HGF-induced CRC cell scattering was abolished by knocking down b-catenin, whereas overexpression of the constitutive active DN-bcat caused a scattered-like phenotype even in non-stimulated cells, and this was further increased by HGF treatment (Figure 4a ). HGF also induced cell motility across the porous membrane of Transwell dishes ( Figure 4b ). As for cell scattering, motility was inhibited in CRC cells transduced with b-catenindirected siRNAs ( Figure 4b ). As b-catenin regulates cell-to-cell contacts through its binding with E-cadherin, we wondered if HGF could affect CRC cell motility by disrupting this interaction, but we found that this was not the case ( Figure 4c ).
Other important biological processes required for the invasion and metastatic spreading of CRC are cell proliferation and survival in the stressful conditions of nutrient deficiency and of lack of cell-matrix interactions. To investigate a possible role of HGFR/b-catenin interactions in these processes, we exposed either wildtype or DN-bcat-transfected CRC cells to the in vitro conditions that mimic nutrient deprivation or anoikis, that is, serum depletion or substrate detachment. We found that both HGF and DN-bcat increased the number of CRC cells in the S/G2/M phases of the cell cycle, either in control conditions or after starvation or detachment (Figure 5a ). The effect of HGFR and b-catenin signaling on cell cycle was additive, as HGF further augmented cell cycle entry of starved or detached DN-bcat-transfected cells (Figure 5a , bottom row).
We also found that either nutrient deprivation or substrate detachment caused formation of hypodiploid nuclei, a terminal cell death marker (sub G0/G1 cells in Figure 5a ). To better evaluate if these stress conditions elicited an apoptotic process, we used a cytofluorimetric technique that allows the simultaneous measurement of independent apoptotic hallmarks (see Materials and methods and Gramaglia et al., 2004; Rasola et al., 2004) . As shown in Figure 5b , either starved or detached cells underwent a massive apoptosis. We therefore asked whether HGFR and/or b-catenin activation could efficiently rescue starved or detached cells. Accordingly, all apoptotic parameters were markedly reduced by HGF treatment or in DN-bcat-CRC cells, and HGF further increased survival of DN-bcat-CRC cells, virtually abrogating apoptosis (Figure 5a and b) . HGF-dependent survival was instead reduced in CRC cells in which b-catenin was knocked down by specific siRNAs (Figure 5b ).
Together, these data show that the interaction between HGFR and b-catenin signaling in CRC cells promotes the HGF-elicited biological subroutines that compose the invasive growth program.
Discussion
In the present work, we provide evidence that a functional circuit connecting the HGF/HGFR transduction pathway and b-catenin/TCF signaling might result in the self-amplifying enhancement of CRC cell invasive growth potential. In fact, we demonstrate the following: HGF increases transcription of the b-catenin/TCF target genes cyclin D1 and c-myc, and by observing an HGF-induced transcriptional enhancement even in conditions of b-catenin oncogenic activation, when TCF-dependent transcription is already markedly increased. This indicates both that HGF mobilizes additional pools of oncogenic b-catenin that do not translocate into the nucleus in resting cells, and that a direct binding between HGFR and b-catenin is not always strictly required for the action of HGF (DN-bcat and HGFR do not interact, data not shown). Notably, these observations imply that HGF might boost the neoplastic potential of CRC cells in an advanced carcinogenic step. (iv) b-Catenin modulates CRC cell scattering and motility, either negatively, as knocking down of b-catenin renders cells refractory to HGF, or positively, as DN-bcat-CRC cells acquire an HGF-independent motile phenotype. These observations could be explained by the b-catenindependent modulation of HGFR expression, even though additional regulatory mechanisms cannot be excluded. (v) Both activated HGFR and b-catenin prompt cell entry into the cycle and cell survival under nutrient deprivation or substrate detachment conditions. HGF also upregulates b-catenin under these same apoptogenic stimuli. Importantly, we find that HGFR controls b-catenin expression through the PI3K pathway, and the PI3K/Akt pathway is a central transducer of survival signals (Franke et al., 2003) , suggesting that b-catenin regulation is part of the survival platform installed by HGF. Actually, Figure 3b . siRNA-bcat cells were infected as in Figure 3a to knock down b-catenin expression.
HGFR activation protects from apoptosis in several tumor in vitro models (Bowers et al., 2000; Fan et al., 2000 Fan et al., , 2005 Gao et al., 2001; Zeng et al., 2002; Derksen et al., 2003; Lal et al., 2005) , and activation of b-catenin promotes the transcription of antiapoptotic genes (Dihlmann et al., 2005; Kim et al., 2005; Ma et al., 2005) and was associated with increased tumor cell survival in CRC (Ireland et al., 2004; Ougolkov et al., 2004) . However, a proapoptotic role of HGF (Arakaki et al., 1998; Matteucci et al., 2003; Rasola et al., 2004) and b-catenin (Kim et al., 2000; van Gijn et al., 2001; Edlund et al., 2005) was also reported in several models. Here, we show that the HGFR transduction axis and the b-catenin/TCF pathway cooperate in underpinning survival signals, whose importance probably increases during carcinoma progression. In fact, HGF dramatically enhances the transcription potential of oncogenic b-catenin, which feeds back the system by augmenting HGFR expression. At the same time, HGF specifically increases b-catenin expression in the stressful conditions met by CRC cells during tumor progression. Moreover, b-catenin activation increases entry into the cell cycle of starved or detached cells, and in these conditions HGF increases TCF-dependent transcription (data not shown).
In conclusion, we have identified an HGFR/b-catenin circuit that amplifies pro-neoplastic biological programs in CRC cells. HGF-treated CRC cells acquire the ability to overcome death insults and become endowed with a motile phenotype. We here identify the regulation of b-catenin signaling and expression level as one of the HGFR downstream targets, and the existence of a positive feedback circuit by which HGFR is regulated by b-catenin itself, and demonstrate that this interplay has important implications in biological processes involved in CRC progression. It is reasonable to think that HGFR accomplishes long-term responses orchestrating a network of transient, epigenetic signals and transcription modulation, which altogether might produce durable regulatory effects in CRC.
Materials and methods
Chemicals and antibodies
Fluorescein isothiocyanate (FITC)-conjugated Annexin-V was from Boehringer Mannheim (Indianapolis, IN, USA); tetramethylrhodamine methyl ester (TMRM) was from Molecular Probes (Eugene, OR, USA); matrigel was from Becton Dickinson Biosciences (San Jose, CA, USA); all other chemicals were from Sigma (St Louis, MO, USA). Anti-HGFR DL21 and DQ13 monoclonal antibodies were homemade; anti-GSK3b and anti-pTyr (p99) rabbit polyclonal antibodies, and anti-actin, anti-phospho-Ser9 GSK3b and anti-b-catenin goat polyclonal antibodies were all from Santa Cruz Biotechnology (Santa Cruz, CA, USA); anti-E-cadherin monoclonal antibody was from Becton Dickinson; antiphospho-b-catenin (Thr41/Ser45) rabbit polyclonal antibody was from Cell Signaling (Beverly, MA, USA).
Cell lines and apoptosis induction COLO741 and HCT116 colorectal cell lines were grown in Roswell Park Memorial Institute (RPMI) medium (Gibco, Grand Island, NY, USA); COS cells were grown in Dulbecco's modified Eagle's medium (Gibco); media were supplemented with 10% fetal bovine serum (Euroclone, Wetherby, UK) and 2 mM L-glutamine. Exponentially growing cells were transfected with Lipofectamine reagent (Invitrogen, Carlsbad, CA, USA). Transfection conditions were titrated with a green fluorescent protein (GFP)-containing plasmid; 6 mg of DNA was normally used for 3 Â 10 5 cells in six multi-well dishes, and transfection efficiency was also assessed by Western blot. Apoptosis was induced by placing exponentially growing cells either in serum-depleted medium or in non-adherent conditions on a poly-HEMA or agarose cushion for 48/72 h. Chemical inhibitors of signal transduction pathways were added 1 h before placing cells in the different apoptotic conditions. As in the following, each experiment was repeated at least five times. Each experimental point was set with or without freshly added HGF at the concentration of 50 ng/ml or control medium. Recombinant HGF was obtained from culture supernatant of Sf9 cells infected with the baculovirus vector containing the full-size human factor. Each experiment was repeated at least twice with pure human recombinant HGF from R&D Systems (Minneapolis, MN, USA).
Flow cytometry analysis of apoptosis induction and of cell cycle
Flow cytometry recordings of independent apoptotic changes were performed by a single-tube analysis, as described by Rasola and Geuna (2001) . Briefly, after induction of apoptosis, cells were resuspended in N-2-hydroxyethylpiperazine-N 0 -2-ethanesulfonic acid (HEPES) buffer (10 mM HEPES, 135 mM NaCl, 5 mM CaCl 2 ) and incubated for 15 min at 371C in FITCconjugated Annexin-V, TMRM (200 nM) and propidium iodide (PI, 1 mg/ml), to detect hallmarks of early, intermediate and late phases of apoptosis. These were, respectively, as follows: loss of the mitochondrial inner membrane electrochemical gradient, measured as reduced TMRM staining; disruption of the plasma membrane asymmetry, assessed by phosphatidylserine exposure on the cell surface and measured as increased FITC-conjugated Annexin-V staining; loss of plasma membrane integrity, assessed by cell permeability and staining with PI. Cell morphology changes were also detected by variations of the forward (FSC) and side light scatter (SSC). Samples were analysed on a FACSCalibur flow cytometer (Becton Dickinson, San Diego, CA, USA). Data acquisition was performed using CellQuest software and data analysis with WinMDI software. FITC-Annexin-V (FL1) and TMRM (FL2) fluorescent signals were displayed on density plot diagrams as arbitrary units of fluorescence on a logarithmic scale. A region was designed on each FITC-Annexin-V vs TMRM diagram and kept constant experiment-by-experiment in order to discriminate between healthy and apoptotic cells. PI-positive, that is, dead, cells were evaluated on a PI vs TMRM diagram not shown in the reported figures. Each experiment was repeated at least five times, and representative diagrams are reported.
Cell cycle was measured by the DNAcon3 kit (ConsulTS, Rivalta, Italy). Briefly, cells were gently lysed with 0.1% Triton X-100 in the presence of RNAse and a chromatin stabilizer, and DNA was stained with 50 mg/ml PI. Samples were kept for 1 h in the dark at room temperature and the DNA index was then measured by cytofluorimetric analysis, using the abovementioned instrument and software. Debris staining was eliminated on a PI area vs PI width diagram. The diploid DNA peak was set on the 200 U value on the x axis of the PI area plot. Hypodiploid, sub-G0/G1 nuclei were defined as those displaying a PI staining value lower than that of diploid cells. Each experiment was repeated at least five times, and representative diagrams are reported.
Western immunoblot analysis
Cytosolic extracts were prepared from cells at 41C in a buffer containing 135 mM NaCl, 20 mM Tris/HCl pH 7.5, 1 mM CaCl 2 and 1% NP-40 in the presence of phosphatase and protease inhibitors (1 mM vanadate, 1 mg/ml leupeptin, 1 mM pepstatin, 1 mM phenyl methyl sulfonyl fluoride, 100 mg/ml soybean trypsin inhibitor). Approximately 1000-1500 mg of extracted protein was used per immunoprecipitation reaction. Extracts were incubated with antibodies conjugated to protein ASepharose beads (Pharmacia, Pfizer, Cambridge, MA, USA) for 2 h at 41C. In the case of monoclonal antibodies, this step was preceded by a preincubation with immunopure rabbit anti-mouse antibodies (Pierce, Rockford, IL, USA) for 30 min at 41C. Beads were then washed twice with a phosphate-buffered saline (PBS) 0.5% NP-40 buffer, once with a Tris-HCl 100 mM, LiCl 0.5 M (pH 7.5) buffer and twice with a Tris-HCl 10 mM, NaCl 0.1 M, ethylenediaminetetraacetic acid 1 mM (pH 7.5) buffer. Proteins extracted from total cell lysates or obtained after immunoprecipitation were then boiled for 5 min in Laemmli sample buffer, separated in reducing conditions on SDS-polyacrylamide gels and transferred onto Hybond-C Extra membranes (Amersham, Little Chalfont, UK) following standard methods. Primary antibodies were incubated for 16 h at 41C, and horseradish peroxidase-conjugated secondary antibodies were added for 1 h. Proteins were visualized by enhanced chemiluminescence (Amersham).
Cell infection with siRNAs b-Catenin siRNA constructs were obtained from a library in which gene-targeting oligonucleotides were cloned downstream to the polymerase III Histone H1-RNA promoter in the pRETROSUPER vector (Berns et al., 2004) . Two different oligonucleotide sequences targeting b-catenin gene were verified by sequencing and used in combination to transduce CRC cell lines. The retroviral supernatants were produced by transfecting the Phoenix cell line with calcium phosphate. MET expression was downmodulated in CRC cells by transduction with the lentiviral vector PCCLsin.PPT.hPGK.GFP.Wpre, used to express siRNA for Met or control siRNA under the control of H1 promoter. The oligonucleotides used were as follows: for Met, 5 0 -GTCA TAGGAAGAGGGCATT-3 0 ; for the control of Met, 5 0 -CTCATAGGAAGACCCCATT-3 0 . Lentivirus production and infection of CRC cells were performed as described previously (Vigna and Naldini, 2000) . One round of infection efficiently downmodulated protein expression level, as assessed by Western blot analysis at 72 h post-infection.
Scatter and motility assays
To measure scattering, cells were grown to confluence in RPMI medium supplemented with 10% fetal calf serum (FCS) in 10-cm Petri dishes. Serum concentration was then progressively lowered to 0%. After 24 h of starvation, cells were plated in 24-well dishes at low density in 2% FCS, stimulated with HGF (10 ng/ml) for 24 h and fixed with a solution containing 3% paraformaldehyde and 2% sucrose in PBS. To perform motility assays, 4 Â 10 4 cells were plated on 6.5 mm plates, in the upper side of a Transwell chamber partitioned by a polycarbonate membrane (8.0 mm pore size, Corning Incorporated, Costar). In the lower part, the chamber was filled with 500 ml of culture medium supplemented with 5% FCS and HGF (50 ng/ml). After 48 h, cells that had crossed the membrane were fixed with 11% glutaraldehyde diluted in PBS, washed twice in PBS and stained with crystalviolet. Stained cells on the lower leaflet of the membrane were photographed and counted with Image Analyzer custom software developed by our group.
Luciferase reporter gene assay
To measure the transcriptional activity of TCF, 2 Â 10 5 cells/ well were seeded in 24-well plates. At 24 h after seeding, cells were transiently transfected with the TCF reporter plasmid (p-TOP-Flash, Upstate Biotechnology, Lake Placid, NY, USA) with or without the DN-bcat construct. DN-bcat encodes an activated form of b-catenin, as it lacks the first 89 amino acids of the full-length protein, a region that encompasses the phosphorylation sites responsible for its proteasomal degradation. DN-bcat was inserted in the pCMV-HA vector (Becton Dickinson Biosciences, Palo Alto, CA, USA) as an XhoI/NotI fragment. At 6 h after transfection, cells were serum-starved for 16 h and HGF (50 ng/ml) was added 2 h before harvesting. Luciferase reporter activity was measured in the Reporter Lysis Buffer of the Luciferase Assay System (Promega, Madison, WI, USA) according to the manufacturer's instructions. Control experiments were performed both with an empty vector and with a negative control TCF reporter plasmid (p-FOP-Flash, Upstate Biotechnology). Ten microliters of cell extracts was used to determine reporter enzyme activity using a Lumat LB 9507 luminometer (Berthold, Bad Wildbad, Germany). Each experimental point was performed in triplicate and luciferase activity was normalized on protein concentration.
Quantitative real-time RT-PCR Total RNA was extracted from culture cells by the TRIzol method (Life Technologies Inc., Beverly, MA, USA) according to the manufacturer's instructions. The RNA samples were quantified using a spectrophotometer, pretreated with DNaseI, and complementary DNA (cDNA) was generated using a reverse transcription kit (Ambion, Austin, TX, USA). Realtime RT-PCR was performed on ABI PRISM 7700 Sequence Detection System using the SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA). Five microliters of 1:8-diluted template cDNA was amplified in a total volume of 25 ml. Real-time PCR analysis was performed using the following primers at indicated concentrations: glyceraldehyde-3-phosphate dehydrogenase (GAPDH): S: 5 0 -GAAGGTGA AGGTCGGAGTC-3 0 , 300 nM; AS: 5 0 -GAAGATGGTGATG GGATTTC-3 0 , 600 nM; c-Myc: S: 5 0 -ATACATCCTGTCCG TCCAAGC-3 0 , 600 nM; AS: 5 0 -TTTCCGCAACAAGTCCTC TTC-3 0 , 600 nM; cyclin D1: S: 5 0 -CCGGAGCATTTTGATA CCAGA-3 0 , 600 nM; AS: 5 0 -AGAGCAAAGGAAAAAACA ACCAA-3 0 , 600 nM; HGFR: S: 5 0 -TGACCTTTAAAAGGCC ATCG-3 0 , 300 nM; AS: 5 0 -CAGAGCATCAGAACCAGAG GC-3 0 , 300 nM; b-catenin: QuantiTect Primer Assay (QT000 77882, Qiagen, Valencia, CA, USA). Cycling was performed at the following conditions: 10 min at 951C, followed by 40 rounds of 15 s at 951C and 1 min at 601C. To verify that the used primer pair produced only a single product, a dissociation protocol was added after thermocycling, determining dissociation of the PCR products from 65 to 951C. A threshold cycle, C t , which correlates inversely with the target cDNA levels, was measured as the cycle number at which the reporter fluorescent emission increased above a threshold level. To quantify target cDNAs, as relative to the zero point, C t of each sample was substracted from the C t0 , and each of them was corrected for the C t of the GAPDH RNA, used as an internal reference and co-amplified with target. The relative quantity of the template (Q) was calculated as: Q ¼ 2 À ðC t À C tr Þ À ðC t0 À C t0r Þ. Three independent RNA preparations were analysed, all samples were run in triplicate and the mean and standard deviation calculated as the square root of: VarðQÞ ¼ e À2m ln 2þ2s 2 ðln 2Þ 2 ½e s 2 ðln 2Þ 2 À 1, where m is the mean of ðC t À C tr Þ À ðC t0 À C t0r Þ and s is the standard deviation (s.d.) To compare measurements from replicate determinations, data from one experimental series were normalized by correcting for the mean ratio between series, and the data were finally averaged.
Immunofluorescence analysis Cells were grown on poly-L-lysine-coated glass coverslips for 48 h, serum-starved for 24 h and then incubated with HGF (50 ng/ml). After 2 h, cells were fixed with 3% paraformaldehyde, permeabilized in HEPES containing 0.2% Triton X-100, washed with PBS and blocked with 2% bovine serum albumin for 30 min. Cells were incubated with an anti-b-catenin goat polyclonal antibody for 30 min at room temperature. Incubation with an anti-goat Alexa Fluor 555-tagged secondary antibody (1:1000, Molecular Probes) was performed in a wet and dark chamber for 30 min. Cells were then incubated for 10 min at room temperature with 300 nM 4 0 ,6-diamidino-2-phenylindole (DAPI) (Sigma). After washes, coverslips were mounted in a Mowiol 4-88 solution (Hoechst, Frankfurt am Main, Germany). Slides were observed on an Olympus 1X71/ 1X51 inverted fluorescence microscope equipped with a charge-coupled device digital camera and images were stored and analysed with the use of the CellR software.
